Breastmit – 2022

04 e 05

/ NOV

TRANSMISSÕES AO VIVO A PARTIDE DE 08h00

3º Simpósio Internacional
de Tratamento Mínimo e
Imagem da Mama

COMISSÃO CIENTÍFICA INTERNACIONAL

Stuart MacIntosh

Nisha Sharma

Ritse Mann

Joerg Heil

Alastair Thompson

Henrique Lima Couto

Fábio Postiglione Mansani

Gil Fascina

Francisco Pimentel Cavalcante

Vilmar Marques de Oliveira

Annamaria Massahud Rodrigues dos Santos

PRINCIPAIS TEMAS ABORDADOS

PALESTRANTES CONVIDADOS INTERNACIONAIS CONFIRMADOS

Alastair M. Thompson

ALCM, BSc(Hons), MBChB, MD, FRCSEd(Gen)

Joerg Heil

MD, PhD

Nisha Sharma

MBChB, BSB(Hons), MRCP, FRCR, MSC

Ritse Mann

MD, PhD

Stuart McIntosh

FAÇA SUA INSCRIÇÃO EVENTO GRATUITO PARA MÉDICOS

RESIDENTES E ACADÊMICOS DE MEDICINA

	ATÉ 30/06/2022	ATÉ 31/08/2022	ATÉ 31/10/2022	A PARTIR DE 01/11/2022
MÉDICO Todas as Especialidades	Gratuito	Gratuito	Gratuito	Gratuito
RESIDENTE E PÓS-GRADUANDOS Todas as Especialidade	Gratuito	Gratuito	Gratuito	Gratuito
ESTUDANTES DE GRADUAÇÃO	Gratuito	Gratuito	Gratuito	Gratuito
OUTROS PROFISSIONAIS	R$ 450,00	R$ 500,00	R$ 550,00	R$ 600,00

OUTROS PROFISSIONAIS

R$ 600,00

EM BREVE PROGRAMAÇÃO CIENTÍFICA

PROGRAMA PRELIMINAR SUJEITO A ALTERAÇÕES PROGRAMAÇÃO CIENTÍFICA

04 Nov
SEXTA-FEIRA
05 Nov
SÁBADO

08:00 - 08:05

ABERTURA

Lorem ipsum dolor sit (UF)

08:05 – 09:05

BREAST CANCER SCREENING – ROUND 01

Coordenador: Lorem ipsum dolor sit (UF)

Debatedor: Lorem ipsum dolor sit (UF)

08:05 – 08:10:

Apresentação

08:10 - 08:25:

Personalized Imaging Screening x Tumoral Circulating Cells Screening – Is it the future?

Palestrante: Lorem ipsum dolor sit (UF)

08:25 - 08:40:

Breast digital tomosynthesis screening. Is it time to change?

Palestrante: Lorem ipsum dolor sit (UF)

08:40 - 08:55:

CESM for breast cancer screening, what is the best place for it?

Palestrante: Lorem ipsum dolor sit (UF)

08:55 - 09:05:

Discussão

09:05 - 09:10

Vídeo patrocinador.

09:10 - 10:25

BREAST CANCER SCREENING – ROUND 02

Coordenador: Lorem ipsum dolor sit (UF)

Debatedor: Lorem ipsum dolor sit (UF)

09:10 – 09:15:

Apresentação

09:15 – 09:30:

Breast Cancer Screening Trials Endpoints and Overdiagnosis

Palestrante: Lorem ipsum dolor sit (UF)

09:30 – 09:45:

RMI or CESM for Breast Cancer Staging, which case it should be standard indicated?

Palestrante: Lorem ipsum dolor sit (UF)

09:45 – 10:00:

CESM second look and guided biopsy.

Palestrante: Lorem ipsum dolor sit (UF)

10:00 – 10:07:

Apresentação oral de abstracts selecionados

Palestrante: Lorem ipsum dolor sit (UF)

10:07 – 10:14:

Apresentação oral de abstracts selecionados

Palestrante: Lorem ipsum dolor sit (UF)

10:14 - 10:25:

Discussão

10:25 – 10:30

Vídeo patrocinador.

10:30 - 11:30

B3 LESIONS AND PERCUTANEOUS PROCEDURES - ROUND 1

Coordenador: Lorem ipsum dolor sit (UF)

Debatedor: Lorem ipsum dolor sit (UF)

10:30 –10:35:

Apresentação

10:35 – 10:50:

Surgery x Vacuum Assisted Excision (VAE) for B3 lesions on core biopsy, how to do you choose it?

Palestrante: Lorem ipsum dolor sit (UF)

10:50 – 11:05:

Vacuum assisted excision and a pathological report of ductal atypia, is there any role for MRI?

Palestrante: Lorem ipsum dolor sit (UF)

11:05 – 11:20:

What skills are requested for Vacuum assisted excision, what are the complications and how to deal with?

Palestrante: Lorem ipsum dolor sit (UF)

11:20 – 11:30:

Discussão

11:30 - 12:15

BREAST CANCER SCREENING STATE OF ART

11:30 – 12:00:

Educational abstract selected

Palestrante: Lorem ipsum dolor sit (UF)

12:00 – 12:15:

Discussão

13:15 - 14:15

DE-ESCALATION FOR DCIS.

Coordenador: Lorem ipsum dolor sit (UF)

Debatedor: Lorem ipsum dolor sit (UF)

13:15 – 13:20:

Apresentação

13:20 – 13:35:

How to assure that it is truly low risk pathological DCIS?

Palestrante: Lorem ipsum dolor sit (UF)

13:35 – 13:50:

De-escalating treatment of low-risk DCIS what should I choose to omit? Surgery x Endocrine therapy x Radiotheraphy x none?

Palestrante: Lorem ipsum dolor sit (UF)

13:50 – 14:05:

How long is safe to wait to start DCIS treatment?

Palestrante: Lorem ipsum dolor sit (UF)

14:05 – 14:15:

Discussão

14:15 – 15:20

Vídeo patrocinador.

14:20 – 15:20

SIMPÓSIO PATROCINADO

15:20 – 15:25

Vídeo patrocinador.

15:25 – 16:25

DE -ESCALATING TREATMENT OF INVASIVE CANCER – ROND 01

Coordenador: Lorem ipsum dolor sit (UF)

Debatedor: Lorem ipsum dolor sit (UF)

15:25 – 15:30:

Apresentação

15:30 – 15:45:

The role of RMI in selecting cases for percutaneous treatment of breast cancer.

Palestrante: Lorem ipsum dolor sit (UF)

15:45 – 16:00:

Is it possible to predict complete resection of small breast cancers by vacuum assisted excision associated with percutaneous sampling (´´shaving``) of cavity margins? Prelimary results of our retrospective series.

Palestrante: Lorem ipsum dolor sit (UF)

16:00 - 16:15:

Selection criteria for Vacuum Assisted Excision for Small Breast Cancers.

Palestrante: Lorem ipsum dolor sit (UF)

16:15 – 16:25:

Discussão

16:25 – 16:30

Vídeo patrocinador.

16:30 - 17:30

DE-ESCALATING RADIOTHERAPHY – ROUND 01

Coordenador: Lorem ipsum dolor sit (UF)

Debatedor: Lorem ipsum dolor sit (UF)

16:30 – 16:35:

Apresentação

16:35 – 16:50:

Omitting RTx based on MRI

Palestrante: Lorem ipsum dolor sit (UF)

16:50 – 17:05:

Five days radiotherapy x intraoperative radiotherapy – What is the best choice for de-escalation?

Palestrante: Lorem ipsum dolor sit (UF)

17:05 – 17:20:

Intraoperative Radiotherapy approaches, is there some to choose?

Palestrante: Lorem ipsum dolor sit (UF)

17:20 - 17:30:

Discussão

17:30 - 18:30

TUMOR BOARD DISCUSSION. REAL LIFE CASES FOR DE-ESCALATION

Coordenador: Lorem ipsum dolor sit (UF)

Debatedor: Lorem ipsum dolor sit (UF)

17:30 – 17:35:

Apresentação

Palestrante: Lorem ipsum dolor sit

17:35 – 17:50:

Axillary observation alone: up front scenario.

Palestrante: Lorem ipsum dolor sit (UF)

17:50 – 18:05:

Axillary biopsy in early breast cancer: does it lead to overtreatment?

Palestrante: Darío M Schejtman (Argentina)

18:05 – 18:30:

Discussão

18:30 - 19:00

DE-ESCALATING LUMINAL BREAST CANCER TREATMENT IN WOMAN OLDER THAN 60 YEARS – STATE OF ART

18:30 – 18:45:

Educational abstract selected

Palestrante: Lorem ipsum dolor sit (UF)

18:45 – 19:00:

Discussão

08:00 - 08:05

ABERTURA

Lorem ipsum dolor sit (UF)

08:05 - 09:05

DE -ESCALATING AXILLAR SURGERY

Coordenador: Lorem ipsum dolor sit (UF)

Debatedor: Lorem ipsum dolor sit (UF)

08:05 – 08:10:

Apresentação

08:10 - 08:25:

Restricted Axillary Staging in Clinically and Sonographically Node-Negative Early Invasive Breast Cancer (c/iT1-2) in the Context of Breast Conserving Therapy

Palestrante: Lorem ipsum dolor sit (UF)

08:25 - 08:40:

One to two not palpable but imaging and histologically positive axillary nodes. Up front surgery x Neoadjuvant Systemic Treatment

Palestrante: Lorem ipsum dolor sit (UF)

08:40 – 08:47:

Apresentação oral de abstracts selecionados

Palestrante: Lorem ipsum dolor sit (UF)

08:47 - 08:54:

Discussão

08:54 - 09:05:

Discussão

09:05 - 09:10

Vídeo patrocinador.

09:10 - 10:10

SIMPÓSIO PATROCINADO

10:10 - 11:00

-----

Coordenador: Lorem ipsum dolor sit (UF)

Debatedor: Lorem ipsum dolor sit (UF)

10:10 - 10:15:

Apresentação

10:15 – 10:35:

For Safety Omitting Surgery after NST what is needed?

Palestrante: Lorem ipsum dolor sit (UF)

10:35 – 10:50:

Axillary Omission of radical axillary surgery after positive sentinel biopsy after NST, is it already in course in clinical practice?

Palestrante: Lorem ipsum dolor sit (UF)

10:50 – 11:00:

Discussão

11:00 – 11:05

Vídeo patrocinador.

11:05 - 11:35

DE-ESCALATING LUMINAL BREAST CANCER TREATMENT IN WOMAN OLDER THAN 60 YEARS – STATE OF ART

11:05 – 11:20:

Educational abstract selected

Palestrante: Lorem ipsum dolor sit (UF)

11:20 – 11:35:

Discussão

11:35 - 12:05

MASTER CLASS

The challenges of de-escalating treatment in breast cancer (patient/clinician acceptability; risks of de-escalating one treatment modality but escalating others e.g. surgery vs RT; challenges of study design – non-inferiority RCT vs cohort studies etc etc)

Palestrante: Lorem ipsum dolor sit (UF)

12:05 – 12:15